688212 澳华内镜
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-6.7530.8551.5304.3701.722
总资产报酬率 ROA (%)-4.3530.6121.2573.7871.542
投入资产回报率 ROIC (%)-4.9540.6981.4104.2151.673

边际利润分析
销售毛利率 (%)63.86165.23968.12469.73869.725
营业利润率 (%)-35.4860.1510.9408.0142.553
息税前利润/营业总收入 (%)-33.3680.4300.8687.5622.424
净利润/营业总收入 (%)-30.3031.3682.7118.9635.626

收益指标分析
经营活动净收益/利润总额(%)74.481-1,045.598-271.80748.7791.151
价值变动净收益/利润总额(%)0.190191.293159.36021.41281.591
营业外收支净额/利润总额(%)1.935-900.763-9.607-0.79633.083

偿债能力分析
流动比率 (X)1.7461.9913.5187.1097.810
速动比率 (X)1.3111.5742.7035.7016.432
资产负债率 (%)36.13433.57521.05612.53212.223
带息债务/全部投入资本 (%)24.22419.0466.264-0.457-0.159
股东权益/带息债务 (%)293.045397.5551,407.790-21,098.455-60,708.664
股东权益/负债合计 (%)174.679195.822371.012690.393710.380
利息保障倍数 (X)-11.8401.03680.309-19.476-1.744

营运能力分析
应收账款周转天数 (天)258.497163.767111.67185.06479.621
存货周转天数 (天)432.333307.288323.600332.882369.936